PYC Therapeutics Ltd
ASX:PYC

Watchlist Manager
PYC Therapeutics Ltd Logo
PYC Therapeutics Ltd
ASX:PYC
Watchlist
Price: 0.185 AUD 5.71% Market Closed
Market Cap: 827.3m AUD
Have any thoughts about
PYC Therapeutics Ltd?
Write Note

PYC Therapeutics Ltd
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

PYC Therapeutics Ltd
Total Liabilities & Equity Peer Comparison

Comparables:
IMM
MSB
CSL
CUV
TLX

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
PYC Therapeutics Ltd
ASX:PYC
Total Liabilities & Equity
AU$91.2m
CAGR 3-Years
16%
CAGR 5-Years
69%
CAGR 10-Years
35%
Immutep Ltd
ASX:IMM
Total Liabilities & Equity
AU$201.6m
CAGR 3-Years
35%
CAGR 5-Years
38%
CAGR 10-Years
23%
Mesoblast Ltd
ASX:MSB
Total Liabilities & Equity
$669.2m
CAGR 3-Years
-4%
CAGR 5-Years
1%
CAGR 10-Years
N/A
CSL Ltd
ASX:CSL
Total Liabilities & Equity
$38B
CAGR 3-Years
28%
CAGR 5-Years
25%
CAGR 10-Years
20%
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Total Liabilities & Equity
AU$231.1m
CAGR 3-Years
29%
CAGR 5-Years
30%
CAGR 10-Years
30%
Telix Pharmaceuticals Ltd
ASX:TLX
Total Liabilities & Equity
AU$406m
CAGR 3-Years
37%
CAGR 5-Years
40%
CAGR 10-Years
N/A

See Also

What is PYC Therapeutics Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
91.2m AUD

Based on the financial report for Jun 30, 2024, PYC Therapeutics Ltd's Total Liabilities & Equity amounts to 91.2m AUD.

What is PYC Therapeutics Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
35%

Over the last year, the Total Liabilities & Equity growth was 145%. The average annual Total Liabilities & Equity growth rates for PYC Therapeutics Ltd have been 16% over the past three years , 69% over the past five years , and 35% over the past ten years .

Back to Top